Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

Oncopeptides

1.46 SEK

+6.33 %

Less than 1K followers

ONCO

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Oncopeptides

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue8.59.931.713.319.220.218.671.1
EBITDA-61.3-84.3-283.5-59.8-56.2-47.1
EBIT-61.3-84.3-283.5-59.8-56.2-47.1-61.5-224.7
EBIT-%-719.7 %-851.1 %-895.7 %-450.9 %-293.2 %-232.8 %-331.3 %-315.9 %
Profit before taxes-60.6-82.6-284.2-60.6-62.8-60.8-64.0-248.2
Net income-60.2-83.4-284.6-60.7-62.9-60.9-65.2-249.6
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.